Approval · Notice of Compliance 12867 · 2011
TEVA-LEVOCARBIDOPA: Notice of Compliance 12867
Issued December 12, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12867
- Date
- December 12, 2011
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer and Product Name Change
- Therapeutic class
- Antiparkinson Agnet
- Canadian reference product
- SINEMET
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-LEVOCARBIDOPA | 02244494 | Dormant |
| TEVA-LEVOCARBIDOPA | 02244495 | Marketed |
| TEVA-LEVOCARBIDOPA | 02244496 | Marketed |